Last update 08 May 2025

FLT3 inhibitors/HDAC inhibitors/VEGFR2 antagonists(Chinese Academy of Medical Sciences and Peking Union Medical College)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Compound 26(Chinese Academy of Medical Sciences and Peking Union Medical College)
Target
FLT3 x HDACs x VEGFR2
Action
inhibitors, antagonists
Mechanism
FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), HDAC inhibitors(Histone deacetylase inhibitors), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Acute Myeloid Leukemia
Inactive Indication-
Originator Organization
Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences
Active Organization
Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with FLT3 inhibitors/HDAC inhibitors/VEGFR2 antagonists(Chinese Academy of Medical Sciences and Peking Union Medical College)
Login to view more data
100 Translational Medicine associated with FLT3 inhibitors/HDAC inhibitors/VEGFR2 antagonists(Chinese Academy of Medical Sciences and Peking Union Medical College)
Login to view more data
100 Patents (Medical) associated with FLT3 inhibitors/HDAC inhibitors/VEGFR2 antagonists(Chinese Academy of Medical Sciences and Peking Union Medical College)
Login to view more data
100 Deals associated with FLT3 inhibitors/HDAC inhibitors/VEGFR2 antagonists(Chinese Academy of Medical Sciences and Peking Union Medical College)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPreclinical
China
Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences
19 Feb 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free